🚨 Applications are now open for our graduate programs! Explore our programs, conduct cutting-edge research, and train alongside world-class faculty. Apply today: https://t.co/Re27cVPHtr
#UTSW#UTSWGradSchool#PhD#MDPhD
🚀 Congrats to Erick and the team on our new publication in Biomaterials!
The study reveals how phospholipids in SORT LNPs enhance mRNA delivery via improving endosomal escape and inducing LNP morphological rearrangements.
Read more: https://t.co/N4nf4xXNA5
#LNP#mRNATherapy
This #throwbackthursday, we are throwing it back to last Friday to celebrate Graduate Student Researcher Joshua Robinson in the @GDE_UTSW Lab, who successfully defended his dissertation. Congratulations, Dr. Robinson!
⭐️Happening Today!
Annual SURF & Amgen Scholars Research Symposium. 🧫🔬🧪
Join us as we celebrate the accomplishments of our scholars and showcase the impactful research they’ve conducted this summer. @UTSWGradSchool @RTPatUTSW @UTSWMedCenter
Our lab member Yufen @YufenXiao gave a fantastic talk on her recent publication: "High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated mRNA therapeutic delivery." at the #CRS2025!
Congrats! 🎉 #mRNA#LNP
The Dallas Morning News recently featured @GDE_UTSW in Rescued by fat bubbles: UTSW scientists treat rare genetic disease with designer molecule. Read the article at the link below.
🚀 New publication from our lab! We found that pKa (6.2–7.4) and buffering capacity may be valuable in predicting in vivo hepatic delivery. #RNAtherapy#LNP
Read more: https://t.co/hV5WhR9arM
Our new 3-component ZAL LNPs simplify mRNA delivery and enable extra-hepatic delivery. Acetate-modified ZALs show enhanced biocompatibility and immune cell transfection—paving the way for next-gen mRNA therapies! 🧬✨ #LNP#mRNA#DrugDelivery
Read more: https://t.co/phEjefdEoq
Our new 3-component ZAL LNPs simplify mRNA delivery and enable extra-hepatic delivery. Acetate-modified ZALs show enhanced biocompatibility and immune cell transfection—paving the way for next-gen mRNA therapies! 🧬✨ #LNP#mRNA#DrugDelivery
Read more: https://t.co/phEjefdEoq
My second journal article publication is out— and it’s my first as first author! Thank you @bypriscila and Crystal Alvarez for your support! Check it out here: https://t.co/nnchHgkJBY
@Human_Kinetics@JMLDjournal
Professor Daniel Siegwart, Ph.D., (@DJSiegwart) will present on the development of SORT lipid nanoparticles (LNPs) for genome correction at #CRISPRMED25 on Thursday, April 10 in Copenhagen, Denmark during the Innovations in Gene-Editing Delivery Systems session.
Congratulations to @YufenXiao, member of the @GDEatUTSW Lab, and team on the publication of “High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics” in @NatureMaterials.
Read it at: https://t.co/AmbCorY0Pt
Recruitment for MSU Infant Walking Study!
We’re looking for infants to participate in a research study! Your little one’s participation will help advance important insights that could benefit future generations.
Interested? Visit our webpage to sign up! https://t.co/pnCKxPfHJU
Thank you to #UTSW Professor @DJSiegwart, Ph.D., who delivered an outstanding first presentation for this year’s President’s Lecture Series! It was a brilliant discussion of “Innovation in Nanotechnology: From Vaccines to Novel Genetic Disease Treatment.”
THIS WEEK!
Join our webinar on Thursday, February 13th, from 11 am-12 pm EST, where we will hear from Trisha Das, Edwin van Oosten, and Josh Robinson, Poster Winners from OTS24.
Learn more and register TODAY!
https://t.co/MLnuGUvIa2
#ots#oligotherapeutics#oligonucleotide
Join us for our Poster Winners #OTS24 Session 2 webinar on Thursday, February 13th from 11 am-12 pm EST!
We will be hearing from Trisha Das, Edwin van Oosten, and Josh Robinson.
Register NOW: https://t.co/MLnuGUvIa2
#ots#oligotherapeutics#oligonucleotide#biotech